![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com/news-release/2024/06/24/2902881/35186/en/Kura-Oncology-Reports-Preclinical-Data-Supporting-Potential-for-Menin-Inhibitor-in-Diabetes.html
https://www.globenewswire.com/news-release/2024/05/14/2881267/35186/en/Kura-Oncology-Completes-Enrollment-in-Registration-Directed-Trial-of-Ziftomenib-in-NPM1-Mutant-AML.html
https://www.globenewswire.com/news-release/2024/05/02/2874668/35186/en/Kura-Oncology-Reports-First-Quarter-2024-Financial-Results.html
https://www.globenewswire.com/news-release/2024/04/22/2866763/35186/en/Kura-Oncology-Receives-Breakthrough-Therapy-Designation-for-Ziftomenib-in-NPM1-Mutant-AML.html
https://www.globenewswire.com//news-release/2024/02/26/2835033/35186/en/Kura-Oncology-Doses-First-Patient-in-KOMET-008-Trial-of-Ziftomenib-in-Combination-with-Standards-of-Care-Including-FLT3-Inhibitor-in-Acute-Myeloid-Leukemia.html
https://www.globenewswire.com/news-release/2024/01/30/2819799/35186/en/Kura-Oncology-Reports-Positive-Preliminary-Ziftomenib-Combination-Data-in-Acute-Myeloid-Leukemia.html
https://www.globenewswire.com//news-release/2023/12/08/2793144/35186/en/Kura-Oncology-s-Menin-Inhibitor-Ziftomenib-Selected-for-The-Leukemia-Lymphoma-Society-s-Pediatric-Acute-Leukemia-PedAL-Master-Clinical-Trial.html
https://www.globenewswire.com/news-release/2023/06/11/2685898/35186/en/Kura-Oncology-Presents-Late-Breaking-Clinical-Data-for-Menin-Inhibitor-Ziftomenib-at-2023-European-Hematology-Association-EHA-Congress.html
https://www.globenewswire.com/news-release/2023/05/10/2666013/35186/en/Kura-Oncology-Reports-First-Quarter-2023-Financial-Results.html
https://www.globenewswire.com/news-release/2022/12/10/2571393/35186/en/Kura-Oncology-Presents-Updated-Clinical-Data-from-KOMET-001-Trial-of-Menin-Inhibitor-Ziftomenib-at-American-Society-of-Hematology-Annual-Meeting.html